Coronavirus: Virus presents greater blood clot risk than vac

The risk of developing blood clots is substantially higher and more prolonged if you contract COVID-19 compared to receiving the Oxford-AstraZeneca or Pfizer-BioNTech vaccines, according to a new study.

Related Keywords

Canada , United Kingdom , Toronto , Ontario , British , Jeffrey Weitz , Julia Hippisley Cox , Pfizer , Astrazeneca , University Of Oxford , Atherosclerosis Research Institute At Mcmaster University , British Medical Journal , Atherosclerosis Research Institute , Mcmaster University , Covid 19 Canada , Pandemic , Yap , Nteractive , Canadians , Anada Coronavirus , Uhan Virus , Uhan Coronavirus , Oronavirus Outbreak , Covid , Covid 19 ,